Who loses
Yes, individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid semaglutide
References 1 KFF, November 2025 2 KFF, November 2025 3 Beth Israel Deaconess Medical Center, November 2024 4 Baylor Scott & White Health, May 2026 5 Tufts Medicine, August 2025 6 Cornell Chronicle, September 2025 7 Curion, March 2026 8 WSJ, GLP-1 Users Are Taking a Bite Out of the Restaurant Business, May 13, 2026 9 Northwestern Now, November 2024 10 Northwestern Now, November 2024 For more information, visit harmelin.com, or connect with us on LinkedIn or Facebook.
SmPCs for all of these medicines are available on the emc, and patient-facing information can be found on the NHS medicines pages